Fate Therapeutics (FATE) Earnings Date, Estimates & Call Transcripts $0.68 -0.09 (-11.69%) Closing price 04:00 PM EasternExtended Trading$0.70 +0.02 (+2.94%) As of 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Fate Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Mar. 5) -$0.31 Beat By $0.13 Consensus EPS (Mar. 5) -$0.44 Fate Therapeutics posted Q4 2024 earnings on March 5, 2025, reporting an EPS of -$0.31, which beat the consensus estimate of -$0.44 by $0.13. Quarterly revenue was reported to be $1.86 million, above analysts' expectations of $1.57 million. With a trailing EPS of -$1.64, Fate Therapeutics' earnings are expected to decrease next year, from ($1.63) to ($1.69) per share. FATE Upcoming EarningsFate Therapeutics' next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Fate Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fate Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataFATE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FATE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Fate Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.46-$0.42-$0.45Q2 20253-$0.48-$0.43-$0.46Q3 20253-$0.49-$0.45-$0.48Q4 20253-$0.50-$0.33-$0.44FY 202512($1.93)($1.63)($1.83) Remove Ads Fate Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------3/5/2025Q4 2024-$0.44-$0.31+$0.13-$0.44$1.57M$1.86M11/12/2024--$0.42-$0.40+$0.02-$0.40$0.88M$3.07M8/13/2024--$0.47-$0.33+$0.14-$0.33$1.47M$6.77M5/9/2024Q1 2024-$0.47-$0.47--$0.47$0.80M$1.93M2/26/2024Q4 2023-$0.57-$0.45+$0.12-$0.45$0.85M$1.68M11/8/2023Q3 2023-$0.59-$0.46+$0.13-$0.46$0.99M$1.94M8/8/2023Q2 2023-$0.58-$0.54+$0.04-$0.54$5.41M$0.93M5/3/2023Q1 2023-$0.55-$0.19+$0.36-$0.19$33.53M$58.98M Fate Therapeutics Earnings - Frequently Asked Questions When is Fate Therapeutics's earnings date? Fate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on FATE's earnings history. Did Fate Therapeutics beat their earnings estimates last quarter? In the previous quarter, Fate Therapeutics (NASDAQ:FATE) reported ($0.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.44) by $0.13. Learn more on analysts' earnings estimate vs. FATE's actual earnings. How much revenue does Fate Therapeutics generate each year? Fate Therapeutics (NASDAQ:FATE) has a recorded annual revenue of $13.63 million. How much profit does Fate Therapeutics generate each year? Fate Therapeutics (NASDAQ:FATE) has a recorded net income of -$160.93 million. FATE has generated -$1.64 earnings per share over the last four quarters. What is Fate Therapeutics's EPS forecast for next year? Fate Therapeutics's earnings are expected to decrease from ($1.63) per share to ($1.69) per share in the next year. More Earnings Resources from MarketBeat Related Companies STOK Earnings Results RGNX Earnings Results MREO Earnings Results ETON Earnings Results RNAC Earnings Results TRDA Earnings Results HRTX Earnings Results DNA Earnings Results TECX Earnings Results UPB Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio? Remove Ads This page (NASDAQ:FATE) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FATE Stock Free FATE Stock Alerts